AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related Diseases Biotech Investing
Merck Announces Phase 3 KEYNOTE-355 Trial Met Primary Endpoint of Overall Survival in Patients with Metastatic Triple-Negative Breast Cancer Whose Tumors Expressed PD-L1 Pharmaceutical Investing
FDA Approves KEYTRUDA® for Treatment of Patients With High-Risk Early-Stage Triple-Negative Breast Cancer in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as Single Agent as Adjuvant Treatment After Surgery Pharmaceutical Investing
HealthTab Adds ID Now Molecular Test Device to Abbott Distribution Agreement, Now Offers First Real-time Reporting of SARS-CoV-2, Flu, Strep and RSV System in Pharmacy Medical Device Investing
Aurinia Pharmaceuticals to Release Second Quarter 2021 Financial Results on August 5, 2021 Biotech Investing
New Data Presented on the Safety and Efficacy of Investigational AGN-190584 as a Potential Novel Treatment for Presbyopia, a Common and Progressive Eye Condition Biotech Investing
DALVANCE® Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients Biotech Investing
Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Johnson & Johnson Investigation Medical Device Investing
Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S. Pharmaceutical Investing
